Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: India Globalization Capital, Inc. IGC

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Management Quoted in “HIGH TIMES” Article

Posted on August 3, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced the publication of “Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work” on August 1, 2017, by … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adds Dr. Chuanhai Cao to Medical Research Team

Posted on August 1, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Dr. Chuanhai Cao has joined its medical research team as a key advisor. “The addition of Dr. … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Financial Results for Fiscal Year Ended March 31, 2017

Posted on July 14, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the fiscal year ended March 31, 2017. “In fiscal 2017, our major accomplishments include … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital’s (NYSE: IGC) Cannabis Drug Development for Alzheimer’s Backed by Previous Studies

Posted on July 13, 2017 by MissionIR

In the U.S., more than 5.3 million people suffer from Alzheimer’s disease, and 46 million around the world have it Alzheimer’s disease cost the U.S. more than $236 billion in 2016, and the global costs topped $600 billion In 2017, … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Featured in Benzinga Article Evaluating Potential of Cannabinoids in Treating Alzheimer’s

Posted on June 30, 2017 by MissionIR

On Thursday, India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, was featured in an article on Benzinga titled ‘Marijuana Could Help Treat Alzheimer’s: Here’s How It Would Work’. The … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) at the Threshold of a Potential Alzheimer’s Breakthrough

Posted on June 28, 2017 by MissionIR

Alzheimer’s is the most ominous and expensive disease in the U.S. IGC is the first and only NYSE MKT-listed pharmaceutical company to develop cannabis-based Alzheimer’s therapies IGC’s patent pending phytocannabinoid therapies to enter clinical trials for potential Alzheimer’s breakthrough A … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Becomes Exclusive Licensee of Cannabis-Based Treatment for Alzheimer’s Disease

Posted on June 12, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its entry into a definitive license agreement with the University of South Florida that makes the company the … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Pursues Clinical Trials of Cannabis-Based Combination Therapies with Assistance of New Advisor

Posted on June 7, 2017 by MissionIR

India Globalization Capital (NYSE MKT: IGC) recently named Craig Cheifetz, M.D. as an advisor to assist the company with its clinical trials in microbiology, immunology, neuroscience and biotechnology. IGC CEO Ram Mukunda stated in a news release that the company … Continue reading →

Posted in India Globalization Capital, Inc. IGC, MissionIRNewsBreaks | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy

Posted on June 6, 2017 by MissionIR

With about 50 million people affected worldwide, drug-resistant epilepsy, or refractory epilepsy, is a very serious condition for which a medical solution has not yet been found, but the therapeutic benefits of phytocannabinoid-based therapies for seizures have been coming under … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment

India Globalization Capital, Inc. (NYSE: IGC) Taps Dr. Craig Cheifetz as Advisor for Clinical Trials of Cannabis-Based Combination Therapies

Posted on May 24, 2017 by MissionIR

India Globalization Capital, Inc. (NYSE MKT: IGC) has named Craig Cheifetz, M.D., as an advisor to aid the company in its clinical trials in microbiology, immunology, neuroscience, and biotechnology. IGC is engaged in the development of cannabis-based therapies, which treat … Continue reading →

Posted in India Globalization Capital, Inc. IGC | Leave a comment